Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katie Stone

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 1, 2007
Immunization with a recombinant MAGE-A3 protein after high-dose therapy for myelomaSusann Szmania, Sacha Gnjatic, Guido Tricot, et al.
Journal of the American Geriatrics Society|August 24, 2018
Rest-Activity Rhythms and Cognitive Decline in Older Men: The Osteoporotic Fractures in Men Sleep StudyTara S Rogers-Soeder, Terri Blackwell, Kristine Yaffe, et al.
Contemporary Clinical Trials|August 9, 2005
Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older menEric Orwoll, Janet Babich Blank, Elizabeth Barrett-Connor, et al.
Plos One|June 27, 2019
Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman diseaseChristopher S Nabel, Stephen Sameroff, Dustin Shilling, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 22, 2014
Ex vivo-expanded natural killer cells demonstrate robust proliferation in vivo in high-risk relapsed multiple myeloma patientsSusann Szmania, Natalia Lapteva, Tarun Garg, et al.
Sleep|June 7, 2022
The genetic etiology of periodic limb movement in sleepJacob L Edelson, Logan D Schneider, David Amar, et al.
The Journal of Clinical Investigation|August 14, 2019
Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman diseaseDavid C Fajgenbaum, Ruth-Anne Langan, Alberto Sada Japp, et al.
JMIR Medical Informatics|April 10, 2025
Identification of Patients With Congestive Heart Failure From the Electronic Health Records of Two Hospitals: Retrospective StudyDaniel Sumsion, Elijah Davis, Marta Fernandes, et al.
Blood|September 6, 2018
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman diseaseFrits van Rhee, Peter Voorhees, Angela Dispenzieri, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 1, 2007
Immunization with a recombinant MAGE-A3 protein after high-dose therapy for myelomaSusann Szmania, Sacha Gnjatic, Guido Tricot, et al.
Journal of the American Geriatrics Society|August 24, 2018
Rest-Activity Rhythms and Cognitive Decline in Older Men: The Osteoporotic Fractures in Men Sleep StudyTara S Rogers-Soeder, Terri Blackwell, Kristine Yaffe, et al.
Contemporary Clinical Trials|August 9, 2005
Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older menEric Orwoll, Janet Babich Blank, Elizabeth Barrett-Connor, et al.
Plos One|June 27, 2019
Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman diseaseChristopher S Nabel, Stephen Sameroff, Dustin Shilling, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 22, 2014
Ex vivo-expanded natural killer cells demonstrate robust proliferation in vivo in high-risk relapsed multiple myeloma patientsSusann Szmania, Natalia Lapteva, Tarun Garg, et al.
Sleep|June 7, 2022
The genetic etiology of periodic limb movement in sleepJacob L Edelson, Logan D Schneider, David Amar, et al.
The Journal of Clinical Investigation|August 14, 2019
Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman diseaseDavid C Fajgenbaum, Ruth-Anne Langan, Alberto Sada Japp, et al.
JMIR Medical Informatics|April 10, 2025
Identification of Patients With Congestive Heart Failure From the Electronic Health Records of Two Hospitals: Retrospective StudyDaniel Sumsion, Elijah Davis, Marta Fernandes, et al.
Blood|September 6, 2018
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman diseaseFrits van Rhee, Peter Voorhees, Angela Dispenzieri, et al.
Pageof 8